Gameto which is a biotechnology company has been awarded a funding of $10 Million from ARPA-H’s Sprint for Women’s Health and this funding will be utilized for the research of Menopause Program “Ameno”.
Gameto receives $10 Million funding from ARPA-H for Women’s Health